Inmagene Biopharmaceuticals
Inmagene is a clinical-stage biotech company developing innovative and differentiated therapies for immunological and inflammatory diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD545—818m (Dealroom.co estimates Jun 2021.)
San Diego California (HQ)
Authorizing premium user...